Evidence map›Paper›PMID 34837635›Full record

ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2022

Effect of the flavonoids quercetin and taxifolin on UVA-induced damage to human primary skin keratinocytes and fibroblasts.

Alena Rajnochová Svobodová, Alena Ryšavá, Kateřina Čížková, Lenka Roubalová, Jitka Ulrichová, Jiří Vrba, Bohumil Zálešák, Jitka Vostálová

Abstract read
PubMed Publisher
In one paragraph

Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Bioactivity Assessment of Functionalized TiOInternational journal of molecular sciences · 2025
    Article
  6. Review
  7. Frontiers in pharmacology · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alena Rajnochová SvobodováDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 77515, Olomouc, Czech Republic.ORCID http://orcid.org/0000-0002-7868-3169
Alena RyšaváDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 77515, Olomouc, Czech Republic.
Kateřina ČížkováDepartment of Histology and Embryology, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 77900, Olomouc, Czech Republic.
Lenka RoubalováDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 77515, Olomouc, Czech Republic.
Jitka UlrichováDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 77515, Olomouc, Czech Republic.
Jiří VrbaDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 77515, Olomouc, Czech Republic.
Bohumil ZálešákDepartment of Plastic and Aesthetic Surgery, University Hospital Olomouc, I. P. Pavlova 6, 77900, Olomouc, Czech Republic.
Jitka VostálováDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 77515, Olomouc, Czech Republic. j.psotova@email.cz.ORCID http://orcid.org/0000-0003-0948-0891
Palacký University Olomouc · CZInstitute of Molecular and Translational Medicine · CZUniversity Hospital Olomouc · CZ

Funding

Univerzita Palackého v Olomouci IGA_LF_2021_011Univerzita Palackého v Olomouci RVO 61989592
6 · The paper itself

Abstract

The ultraviolet (UV) part of solar radiation can permanently affect skin tissue. UVA photons represent the most abundant UV component and stimulate the formation of intracellular reactive oxygen species (ROS), leading to oxidative damage to various biomolecules. Several plant-derived polyphenols are known as effective photoprotective agents. This study evaluated the potential of quercetin (QE) and its structurally related flavonoid taxifolin (TA) to reduce UVA-caused damage to human primary dermal fibroblasts (NHDF) and epidermal keratinocytes (NHEK) obtained from identical donors. Cells pre-treated with QE or TA (1 h) were then exposed to UVA light using a solar simulator. Both flavonoids effectively prevented oxidative damage, such as ROS generation, glutathione depletion, single-strand breaks formation and caspase-3 activation in NHDF. These protective effects were accompanied by stimulation of Nrf2 nuclear translocation, found in non-irradiated and irradiated NHDF and NHEK, and expression of antioxidant proteins, such as heme oxygenase-1, NAD(P)H:quinone oxidoreductase 1 and catalase. For most parameters, QE was more potent than TA. On the other hand, TA demonstrated protection within the whole concentration range, while QE lost its protective ability at the highest concentration tested (75 μM), suggesting its pro-oxidative potential. In summary, QE and TA demonstrated UVA-protective properties in NHEK and NHDF obtained from identical donors. However, due to the in vitro phototoxic potential of QE, published elsewhere and discussed herein, further studies are needed to evaluate QE safety in dermatological application for humans as well as to confirm our results on human skin ex vivo and in clinical trials.

Indexed as

FlavonoidsQuercetinFibroblastsHumansKeratinocytesOxidative StressSkinUltraviolet RaysFlavonoidsQuercetintaxifolinFlavonoidsHuman skin fibroblastsHuman skin keratinocytesNuclear factor Nrf2Oxidative stressUVA radiation

Identifiers

PMID34837635
OpenAlexW3215872197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.